Seminars in Oncology Nursing
Volume 25, Issue 2 , Pages 159-169 , May 2009

Survivorship Issues in Hematopoietic Stem Cell Transplantation

  • Patricia C. Buchsel

      Affiliations

    • Corresponding Author InformationAddress correspondence to Patricia C. Buchsel, RN, MSN, FAAN, Seattle University, Seattle University College of Nursing Clinical Faculty, 901 12th Ave, PO Box 222000, Seattle, WA 98122-1090

References 

  1. Horwitz ME, Sullivan KM. Chronic graft versus host disease. Blood Reviews. 2006;20:1515–1527
  2. Couriel D, Carpenter PA, Culter C, et al. Ancillary therapy and supportive care working groups report. National institutes of health consensus development project on criteria for clinical trials in chronic graft versus host disease: VI. Biol Blood Marrow Transplant. 2006;12:375–396
  3. Committee on Cancer Survivorship. Improving care and quality of life. From cancer patient to survivor. Lost in translation. Washington, DC: The National Academies Press; Institute of Medicine and National Research Council of the National Academies; 2006;
  4. Applebaum F. Hematopoietic-cell transplantation at 50. N Engl J Med. 2007;157:1427–1475
  5. Bahatia S, Francisco L, Carter A, et al. Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the marrow and Bone Marrow Transplant Survivor Study. Blood. 2007;110:3748–3792
  6. Bhatia S, Robison LL, Francisco L, et al. Late mortality in survivors of autologous hematopoietic-cell transplantation: report from the Bone Marrow Transplant Survivor Study. Blood. 2005;105:4215–4222
  7. Tichelli A, Passweg J, Wójcik D, et al. Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation. Haematologica. 2008;93:1203–1210
  8. Nursing Education Group. Cardiac late effectsafter HSCT. European Group for Marrow and Blood Transplantation. April 2008. Available at: http://www.ebmt.org/6nursesgroup/ng_documents/ngdocs/education2007%202008/late%20effects%20post%20hsct%20-%20cardiopulmonary%20-%20a%20ticelli.pdf. (accessed Feb 4, 2009).
  9. Girindra RG, Wingard JR, Mehta P. Bone marrow transplantation, long-term effects. E-medicine from WebMD. Available at: http://emedicine.medscape.com/article/989518-overview. (accessed Dec 27, 2008).
  10. Deeg HJ, Socie G. Malignancies after hematopoietic stem cell transplantation: many questions, some answers. Blood. 1998;91:1833–1834
  11. Baker KS, Gurney JG, Ness A, et al. Late effects in survivors in chronic myeloid leukemia treated with hematopoietic cell transplant: results from the Bone Marrow Transplant Survivor Study. Blood. 2004;104:1898–1906
  12. Kolb HJ, Socié G, Duell T, et al. Malignant neoplasms in long-term survivors of bone marrow transplantation. Late Effects Working Party of the European Cooperative Group for Blood and Marrow Transplantation and the European Late Effect Project Group. Ann Intern Med. 1999;131:738–744
  13. Curtis RE, Rowlings PA, Degg J, et al. Solid cancers after bone marrow transplantation. N Engl J Med. 1999;336:897–904
  14. Yao S, McCarthy PL, Dunford LM, et al. High prevalence of early-onset osteopenia/osteoporosis after allogeneic stem cell transplantation and improvement after bisphosphonate therapy. Bone Marrow Transplant. 2008;41:393–398
  15. Zadegan F, Raould A, Bizot P, et al. Osteonecrosis after allogenic bone marrow transplantation. Clinical orthopaedics and related research. 2008;46:287–293
  16. Wiesmann A, Pereria P, Faul C, et al. Avascular necrosis of bone following allogeneic stem cell transplantation: MR screening and therapeutic options. Bone Marrow Transplant. 1998;22:565–569
  17. Lee SJ, Vogelsang G, Gilman A, et al. A survey of diagnosis, management, and grading of chronic GVHD. Biol Blood Marrow Transplant. 2002;8:32–39
  18. Cohen A, Bekassy AN, Gaiero A, et al. Endocrinological late complications after hematopoietic SCT in children. Bone Marrow Transplant. 2008;41(suppl):543–548
  19. Sanders J. Growth and development after hematopoietic cell transplant. In:  Thomas ED,  Blume KG,  Forman SJ editor. Hematopoietic stem cell transplantation. Ed 2. Malden, MA: Blackwell Science; 1999;p. 746–775
  20. Narumi S, Shimada H, Shimasaki N, et al. Growth-chart-based qualitative evaluation of height growth after hematopoietic stem cell transplantation. Pediatr Transplant. 2006;10:26–31
  21. Campbell J, Moravec CK. Long term complications of hematopoietic stem cell transplantation. In:  Buchsel PC,  Kapustay P editor. Stem cell transplantation clinical textbook. Pittsburgh, PA: Oncology Nursing Press; 2008;23.3-23.16
  22. Shah AJ, Epport K, Azen C, et al. Progressive declines in neurocognitive function among survivors of hematopoietic stem cell transplantation for pediatric hematologic malignancies. J Pediatr Hematol Oncol. 2008;30:411–418
  23. Pasquini M, Wang Z, Schneider L. Report on the state of the art in blood and marrow transplantation. International Bone Marrow Transplant Registry/Autologous Blood & Marrow Transplant Registry Newsletter. December 2007;12:5–9
  24. Joseph RW, Couriel DR, Komanduri K. Chronic graft -versus host-disease after allogeneic transplantation: challenges in prevention, science, and supportive care. J Support Care Oncol. 2008;8:361–372
  25. Martin P, Weisdorf D, Prezepiorka D, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft versus host disease: VI. Ancillary Therapy and Supportive Care Working Groups Report. Biol Blood Marrow Transplant. 2006;12:491–505
  26. Filipovich AH, Weisdorf D, Pavletic S, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant. 2005;11:945–956
  27. Chouinard MS. Nursing management of the nonmyeloablative hematopoietic stem cell transplantation recipient. In:  Buchsel PC,  Kapustay P editor. Stem cell transplantation clinical textbook. Pittsburgh, PA: Oncology Nursing Press; 2006;20.3-20.11
  28. Shlochik WD, Lee SJ, Couriel D, et al. Transplantation's greatest challenges: advantages in chronic graft-versus-disease. Biol Blood Marrow Transplant. 2008;14:142–150
  29. Teshima T, Wynn TA, Soiffer RJ, et al. Chronic graft-versus-host disease: how can we release Prometheus?. Biol Blood Marrow Transplant. 2008;14:142–150
  30. Komanduri KV, Couriel D, Champlin RE. Graft versus-host disease after allogeneic stem cell transplantation: evolving concepts and novel therapies including photopheresis. Biol Blood Marrow Transplant. 2006;12(suppl 2):1–6
  31. Flowers MED, Apperley JF, van Besien K, et al. A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease. Blood. 2008;112:2667–2674
  32. Keever-Taylor CA, Bredeson C, Loberiza FR, et al. Analysis of risk factors for the development of GVHD after T-cell depleted allogeneic B: effect of HLA-disparity, ABO incompatibility, and method of T-cell depletion. Biol Blood Marrow Transplant. 2001;7:620–630
  33. Kernan NA, Bordignon C, Heller G, et al. Graft failure after T-cell-depleted human leukocyte antigen identical marrow transplants for leukemia: I. Analysis of risk factors and results of secondary transplants. Blood. 1989;1(74):2227–2236
  34. DeMeyer ES, Buchsel PC. A dendritic cell primer for oncology nurses. Clin J Oncol Nurs. 2005;9:460–464
  35. Buchsel PC, DeMeyer E. Dendritic cells: emerging roles in immunotherapy. Clin J Oncol Nurs. 2006;10:629–640
  36. T-regulatory cell infusion after an umbilical cord blood transplant in treating patients with advanced hematologic cancer or other disorders. NCT no. 00602693. Available at: clinicaltrials.gov/ct2/show/NCT00602693 (accessed Jan 4, 2009).
  37. Martins SL, St John LS, Champlin RE, et al. Functional assessment and specific selective depletion of donor alloreactive human T cells using flow cytometry Blood. 2004;104:342–346

PII: S0749-2081(09)00022-9

doi: 10.1016/j.soncn.2009.03.003

Seminars in Oncology Nursing
Volume 25, Issue 2 , Pages 159-169 , May 2009

Article Tools

* Image Usage & Resolution